Posted by Michael Wonder on 02 Aug 2018
Institute for Clinical and Economic Review lists potential options for assessments in 2019
2 August 2018 - ICER will select 2019 topics from a wide range of treatments, medical devices, and IT-based interventions.
The ICER has released its preliminary list of potential assessment topics for 2019. The list is drawn from ICER horizon scans of new and emerging therapies, conversations with stakeholders, and suggestions submitted from the public.
ICER’s topic selection criteria – including the projected timing and likelihood of FDA approval, and whether a review of the evidence would suggest specific actions for payers, physicians, patients, and policymakers to improve clinical practice – are applied to produce this preliminary list of potential topics.
